Fig. 1From: Mutation status coupled with RNA-sequencing data can efficiently identify important non-significantly mutated genes serving as diagnostic biomarkers of endometrial cancerFramework for identifying the non-SMGs associated with clinical endpoints and validating their phenotypic relevance in ECsBack to article page